Increased Prevalence Of Infectious Diseases Fuels Growth In The Plant-Based Vaccine Market Is Supporting Development Across The Plant-Based Vaccines Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Plant-Based Vaccines Market Increase Between 2026 And 2030?

The plant-based vaccines market has experienced rapid expansion in its size over recent years. It is projected to expand from $1.81 billion in 2025 to reach $1.99 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.2%. Historically, this expansion can be linked to several factors, including insufficient cold chain infrastructure in developing regions, the substantial expense of traditional vaccine manufacturing, a rise in zoonotic disease prevalence, initial academic efforts in plant molecular farming, and governmental backing for alternative biologics.

The plant-based vaccines market is projected to experience swift expansion over the coming years. The market is anticipated to reach $3.06 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. This forecasted growth is attributable to several factors, including an increasing need for scalable vaccine technologies, expansion in pandemic preparedness initiatives, heightened investment in plant biotechnology ventures, the requirement for economical veterinary vaccines, and advancements in the regulatory landscape for new vaccine platforms. Key developments expected during this period involve the broader application of recombinant antigen expression within plants, a growing embrace of plant-based solutions for animal vaccines, an intensified emphasis on creating oral and edible vaccines, increased financial backing from both public and private sectors for unconventional vaccine approaches, and continuous improvements in purification and downstream processing techniques.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

Which Major Factors Are Contributing To The Development Of The Plant-Based Vaccines Market?

The widespread occurrence of infectious diseases is anticipated to drive the expansion of the plant-based vaccines market moving forward. These conditions, caused by pathogenic microorganisms like bacteria, viruses, or parasites, can disseminate directly or indirectly, presenting substantial global health concerns. The escalation in cases of infectious diseases is attributed to elements such as heightened global mobility, congested urban areas, and diminished immunity within specific demographics. Plant-derived vaccines present innovative platforms capable of swift scaling and adaptation to confront these growing health challenges. For instance, in March 2024, the Centers for Disease Control and Prevention (CDC), a US-based federal agency, reported that the number of tuberculosis (TB) cases increased from 8,320 in 2022 to 9,615 in 2023, a rise of 1,295 cases. Consequently, the high prevalence of infectious diseases is a key factor propelling the growth of the plant-based vaccines market.

What Segment Types Are Included In The Plant-Based Vaccines Market Analysis?

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

Which Trends Are Shaping The Plant-Based Vaccines Market Landscape?

Leading entities within the plant-based vaccines market are establishing strategic manufacturing alliances to broaden their clinical-stage production capacities and expedite the progression of advanced VLP-based vaccines. The primary objectives of these strategic manufacturing partnerships include boosting downstream processing efficiency, guaranteeing manufacturing adherence to GMP standards, and facilitating a smooth progression from initial research phases to clinical development. An illustrative example is the collaboration in December 2024 between Aramis Biotechnologies Inc., a Canadian firm focused on plant-based biomanufacturing of novel vaccines, and Biodextris Inc., another Canada-based CDMO known for its expertise in cGMP complex biologic products. This partnership was formed to provide support for Phase 1 and Phase 2 clinical trials. Through this joint effort, the collaborating entity will undertake purification, formulation, and fill-finish operations for the plant-expressed VLP vaccine candidates, which is anticipated to facilitate more rapid scale-up, elevate production quality, and bolster preparedness for advanced clinical evaluation.

Who Are The Major Companies Operating In The Plant-Based Vaccines Market?

Major companies operating in the plant-based vaccines market are British American Tobacco PLC, Medicago Inc., Creative Biolabs Inc., Fraunhofer USA Inc., Biodextris Inc., Avesthagen Limited, Calyxt Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG, Zyus Life Sciences Inc., Agenus Inc.

Access The Complete Plant-Based Vaccines Market Report:

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

Which Region Accounts For The Highest Share Of The Plant-Based Vaccines Market?

North America was the largest region in the plant-based vaccines market in 2025. The regions covered in the plant-based vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Plant-Based Vaccines Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

Browse Through More Reports Similar to the Global Plant-Based Vaccines Market 2026, By The Business Research Company

Plant Based Proteins Market 2026

https://www.thebusinessresearchcompany.com/report/plant-based-proteins-market

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Preventive Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/preventive-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795